Michael Shetzline, CMO, SVP, Head-Res&Drug at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 20,648 shares at $10.12 ($209K) on 2023-05-22, disclosed to the SEC on 2023-05-24.
Open-market sale of $209k IRWD by CMO, SVP, Head-Res&Drug. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.12 | 10,324 | $104K | 50.0% |
| 2 | $10.12 | 10,324 | $104K | 50.0% |
| Total | $10.12 avg | 20,648 | $209K | 100% |
| Filing → |
| IRWD | SELL | 2024-05-22 | $208K | — | Filing → |
| IRWD | SELL | 2024-02-14 | $1.2M | — | Filing → |
| IRWD | SELL | 2023-03-01 | $385K | — | Filing → |